Study to Evaluate the Trough and Peak Effect of Once Daily Telmisartan 80 mg/Hydrochlorothiazide 12.5 mg (Micardis Plus) by Ambulatory Blood Pressure Monitoring (ABPM) in Patients With Mild to Moderate Essential Hypertension

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

August 31, 2006

Study Completion Date

August 31, 2006

Conditions

Hypertension

Interventions

DRUG

Telmisartan

DRUG

Telmisartan/HCTZ

Trial Locations (1)

Shanghai Ruijin Hospital, Shanghai